Form 4 · Filed Jul 13, 2026, 09:09 PM UTC
ORKA/Oruka Therapeutics, Inc.
Agarwal Arjun — Senior Vice President, Finance
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
8 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | M | other | 8,541 | $13 | $106,763 | 23,853 |
| Jul 13, 2026 | M | other | 1,458 | $34 | $50,141 | 25,311 |
| Jul 13, 2026 | S | sell | 300 | $83 | $24,920 | 25,011 |
| Jul 13, 2026 | S | sell | 3,743 | $84 | $315,369 | 21,268 |
| Jul 13, 2026 | S | sell | 5,656 | $85 | $480,201 | 15,612 |
| Jul 13, 2026 | S | sell | 300 | $86 | $25,690 | 15,312 |
| Jul 13, 2026 | M | other | 8,541 | — | — | 101,459 |
| Jul 13, 2026 | M | other | 1,458 | — | — | 61,250 |
Source: SEC EDGAR raw filing ↗ · Accession 0000907654-26-000071